uridine diphosphate n-acetylglucosamine has been researched along with folic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Chen, T; Fang, X; Fu, Y; Gu, J; Li, H; Li, Y; Liu, X; Shang, M; Wang, T; Xiao, J; Yang, H; Yang, R; Yu, Q; Zhang, J; Zhang, K; Zhang, Q | 1 |
1 other study(ies) available for uridine diphosphate n-acetylglucosamine and folic acid
| Article | Year |
|---|---|
The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
Topics: Aminohydrolases; Animals; B7-H1 Antigen; Carcinogenesis; Cell Line, Tumor; Embryo, Mammalian; Fibroblasts; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Multifunctional Enzymes; Pancreatic Neoplasms; Primary Cell Culture; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Signal Transduction; T-Lymphocytes, Cytotoxic; Tumor Burden; Tumor Escape; Uridine Diphosphate N-Acetylglucosamine; Xenograft Model Antitumor Assays | 2021 |